Nesiritide

N/A

Report date: 2023/03/22 14:41:34
NME

Base Information

Drug NameNesiritide
Drug Alias Name奈西立肽Brain natriuretic peptidenesiritidum奈西利肽B-Type natriuretic peptide +[12] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsAcutely decompensated congestive heart failureObesityHyperinsulinism +[15] 
Global Approved IndicationsAcutely decompensated congestive heart failureHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2001/08/10
Country/TerritoryBulgariaCanadaUnited States +[29] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPending
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oslo
Inactive CompaniesScios IncThe Brigham and Women's HospitalAdventHealth Translational Research Institute +[13] 
Active IndicationsHypertension
Inactive IndicationsAcutely decompensated congestive heart failureObesityHyperinsulinism +[14] 

Other Information

ATC CodeC01DX19
Related LinksWikipediaDrugBankKEGG